PHARMACY CARE NICOTINE LOZENGES 2mg nicotine (as nicotine polacrilex) lozenge blister pack

Χώρα: Αυστραλία

Γλώσσα: Αγγλικά

Πηγή: Department of Health (Therapeutic Goods Administration)

Δραστική ουσία:

nicotine polacrilex, Quantity: 13.33 mg (Equivalent: nicotine, Qty 2 mg)

Διαθέσιμο από:

Orion Laboratories Pty Ltd T/A Perrigo Australia

INN (Διεθνής Όνομα):

Nicotine polacrilex

Φαρμακοτεχνική μορφή:

Tablet, uncoated

Σύνθεση:

Excipient Ingredients: aspartame; xanthan gum; mannitol; sodium alginate; sodium carbonate; magnesium stearate; potassium bicarbonate; Flavour

Οδός χορήγησης:

Buccal

Μονάδες σε πακέτο:

36, 156, 168, 96, 132, 144, 108, 120, 72

Τρόπος διάθεσης:

Not Scheduled after consideration by Committee

Θεραπευτικές ενδείξεις:

Relief of nicotine withdrawal symptoms including cravings associated with smoking cessation. Nicotine Lozenges may also be used as part of a smoking reduction strategy by smokers who are unable or not ready to stop smoking abruptly as a step towards stopping smoking. If possible, when stopping smoking, should be used in conjunction with behavioural support program.

Περίληψη προϊόντος:

Visual Identification: Cream/white embossed biconvex round tablet with an odour of peppermint. Embossed with 'L344' on one face.; Container Type: Blister Pack; Container Material: PVC/PCTFE (Aclar)/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

Καθεστώς αδειοδότησης:

Licence status A

Ημερομηνία της άδειας:

2014-12-16